Q3 FY2026 · ended Sep 30, 2026 · Revenue $72.66M, +18.6% YoY · Filed Oct 28, 2026
OrthoPediatrics Corp (KIDS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $72.7 million and a net loss of $5.9 million. Free cash flow was $1.6 million. As of Sep 30, 2026 it held $44.2 million in cash and investments and $104.6 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KIDS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Warsaw, IN
- SEC filer status
- Accelerated filer
- SEC CIK
- 1425450
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $72.7M | $70.5M | $59.4M | $61.6M | $61.2M |
| Operating income | -$4.2M | -$4.1M | -$8.3M | -$8.2M | -$9.4M |
| Net income | -$5.9M | -$7.2M | -$10.7M | -$10.1M | -$11.8M |
| Diluted EPS | -$0.25 | -$0.30 | -$0.45 | -$0.43 | -$0.50 |
| Operating cash flow | $4.5M | $928,000 | -$3.3M | $10.3M | -$581,000 |
| Free cash flow | $1.6M | -$3.1M | -$5.0M | $9.7M | -$3.4M |
| Total assets | $509.1M | $511.4M | $502.2M | $508.6M | $493.5M |
| Total liabilities | $169.7M | $167.8M | $163.5M | $162.0M | $144.2M |
| Stockholders' equity | $339.4M | $343.6M | $338.7M | $346.6M | $349.3M |
| Cash and investments | $44.2M | $45.9M | $48.8M | $60.9M | $57.7M |
| Total debt | $104.6M | $105.8M | $106.7M | $118.0M | $105.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
All 628 OrthoPediatrics Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.